Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

The FDA approved a 21-valent pneumococcal conjugate vaccine (Capvaxive) for preventing invasive pneumococcal disease and pneumococcal pneumonia in adults, Merck announced on Monday. Specifically designed

BOSTON – Patients with a penicillin allergy may be delabeled based on methods that don’t require specialist intervention or other more resource-intensive testing, a researcher